Abstract | PURPOSE: METHODS: bFGF expression was analyzed in the LH-betaTag transgenic mouse model of RB and human RB cell lines by immunofluorescence, RT-PCR, and Western blot. Proliferation and apoptosis (TUNEL) assays were performed. RESULTS: bFGF levels significantly increased during tumorigenesis in transgenic RB, as a function of tumor status (P = 0.005). PCR and confocal microscopy confirmed that the human cell lines and primary tumors expressed bFGF. bFGF was localized to vascular and tumor cells and rarely to glial cells. Exogenous 18-kDa bFGF induced proliferation in two RB cell lines (WERI and Y79). Western blot analysis demonstrated 34-, 22-, and 18-kDa isoforms in transgenic RB and both cell lines. In TUNEL assays, chemoresistance to carboplatin-induced apoptosis was observed in the Y79 line, which expressed a higher ratio of high (34 kDa)- to low-molecular-weight bFGF isoforms, compared with the WERI line. Similar to other bFGF tumor studies, exogenous low-molecular-weight (18 kDa) bFGF (1 ng) significantly enhanced carboplatin-induced apoptosis in the more chemosensitive WERI, but not the chemoresistant Y79 line. CONCLUSIONS: RB tumors produce significant amounts of bFGF, and the differential production and response to isoforms of bFGF may have implications for invasive tumor growth and chemoresistance.
|
Authors | Colleen M Cebulla, Maria-Elena Jockovich, Yolanda Piña, Hinda Boutrid, Armando Alegret, Amy Kulak, Abigail S Hackam, Sanjoy K Bhattacharya, William J Feuer, Timothy G Murray |
Journal | Investigative ophthalmology & visual science
(Invest Ophthalmol Vis Sci)
Vol. 49
Issue 12
Pg. 5215-21
(Dec 2008)
ISSN: 1552-5783 [Electronic] United States |
PMID | 18614803
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antineoplastic Agents
- Fibroblast Growth Factor 2
- Carboplatin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Blotting, Western
- Carboplatin
(pharmacology)
- Cell Proliferation
(drug effects)
- Disease Models, Animal
- Disease Progression
- Drug Resistance, Neoplasm
- Fibroblast Growth Factor 2
(metabolism, pharmacology)
- Fluorescent Antibody Technique, Indirect
- Gene Expression Regulation, Neoplastic
(physiology)
- Humans
- In Situ Nick-End Labeling
- Mice
- Mice, Transgenic
- Microscopy, Confocal
- Retinal Neoplasms
(drug therapy, metabolism, mortality)
- Retinoblastoma
(drug therapy, metabolism, mortality)
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Rate
- Tumor Cells, Cultured
(metabolism)
|